HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICC
Clinical trial NCT06335927 · UNKNOWN
Trial details
- NCT number
- NCT06335927
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-11
- Primary completion
- 2025-05-10
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.